Biosimilars: An Overview for Clinicians
  • Program Overview
    Biosimilars: An Overview for Clinicians
    In this CME-certified educational activity, experts in oncology and immunology answer your most frequently asked questions about biosimilars, including:
    -How biosimilars differ from their reference biologic and small molecule generics
    -Safety, efficacy, and regulatory approval pathways
    -Potential role in oncology and immunology

Latest Content

3 of 3 Shown
3 of 3 Shown
Show 0 More
What questions do you have related to biosimilars and their use?
Let us know! Expert faculty will select the most common questions to answer in an upcoming activity.
Please log in to submit your question